Capricor Therapeutics
CAPR
#7980
Rank
NZ$0.50 B
Marketcap
NZ$10.99
Share price
-4.36%
Change (1 day)
-57.31%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.14 Billion

According to Capricor Therapeutics 's latest financial reports the company has NZ$0.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.25 B621.69%
2023-12-31$NZ$35.73 M92.52%
2022-12-31$NZ$18.56 M-59.58%
2021-12-31$NZ$45.92 M17.5%
2020-12-31$NZ$39.08 M284.85%
2019-12-31$NZ$10.15 M47.58%
2018-12-31$NZ$6.88 M-56.47%
2017-12-31$NZ$15.8 M-373.53%
2016-12-31$-NZ$5.78 Million283.35%
2015-12-31$-NZ$1.51 Million-81.1%
2014-12-31$-NZ$7.98 Million1125.27%
2013-12-31$-NZ$0.66 Million-110.94%
2012-12-31$NZ$5.94 M458.97%
2011-12-31$NZ$1.06 M-68.38%
2010-12-31$NZ$3.36 M-18.02%
2009-12-31$NZ$4.1 M-53.31%
2008-12-31$NZ$8.79 M-55.68%
2007-12-31$NZ$19.84 M-10472.43%
2006-12-31$-NZ$0.2 Million68.45%
2005-12-31$-NZ$0.12 Million37.9%
2004-12-31$-NZ$0.09 Million31.58%
2003-12-31$-NZ$0.07 Million33.54%
2002-12-31$-NZ$0.05 Million117.65%
2001-12-31$-NZ$0.03 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Cytokinetics
CYTK
-NZ$0.91 Billion-721.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$11.04 Million-107.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$136.96 B 94,426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$5.18 B 3,481.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.03 B 613.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$6.16 M-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA